AmCham IPL Committee sees progress and challenges China Post, Taiwan - The burden is left to the pharmaceutical company to monitor the market and take legal action if patents are being violated. Currently, said Shapiro ... |
Monday, August 11, 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment